Searched for
TRUMP PRESSURES PHARMA CEOS
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- OpenAI, Anthropic limit new AI models to Trump-approved customers during cybersecurity reviewAI giants OpenAI and Anthropic are facing unprecedented government scrutiny over their powerful new models. The Trump administration has re...
- Trump clean energy tax credit cutoff drives project rush as prices set to soarThe phaseout of the 20-year-old subsidies, accelerated under President Donald Trump's 2025 tax law, could drive contract prices for wind ...
- Who is Shankh Mitra? The Indian-origin CEO who became the world's second-highest paid executive in 2025 after Elon MuskIndian-origin Shankh Mitra, CEO of Welltower, has been named the world's second-highest paid executive in 2025 with an $821 million package...
- Lockheed Martin gets $35 billion Thaad deal as Trump looks to stockpile weaponsPresident Trump is convening with top defense executives to accelerate weapons production, addressing depleted U.S. stockpiles after extens...
- US Senate sides with Trump in fresh vote on Iran war powersUS Senate narrowly rejected a resolution to curb President Trump's Iran war powers, a day after passing a similar measure. Republican senat...
- Donald Trump cancels housing bill signing to pressure Republicans on voting billPresident Trump has postponed a housing bill signing to push Republican senators for passage of his voting restrictions, the SAVE America A...
- Iran says deal to end Mideast war 'declaration of US defeat'Iran's chief negotiator, Mohammad Bagher Ghalibaf, declared the recent deal with the US to end the Middle East war as "America's declaratio...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Starmer seen as likely to announce exit timetable as rival Burnham heads to UK ParliamentUK Prime Minister Keir Starmer is reportedly considering stepping down as early as Monday, facing pressure from within the Labour Party. Th...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- High blood pressure? Top nutritionist reveals the best fruits, vegetables and seeds to add to your dietNutritionist Sonia Narang, who has advised prominent Indian leaders, shared everyday foods that can aid blood pressure management. She reco...
- Trump tells Axios he no longer views Anthropic as national security threatSenior Anthropic technical staff were scheduled to meet with Trump administration officials earlier this week to discuss a dispute over f...
- Trump tells Axios he no longer views Anthropic as national security threatFormer President Donald Trump initially perceived AI firm Anthropic as a national security risk, but has since changed his stance. This shi...
Load More
